Aston Science
Manufacturing · South Korea · 11-50 Employees
View Company Info for Free
Overview
Headquarters
10f 40 Seolleung-ro 90-gil, Seoul, Seoul...Phone Number
+82 220382347Website
www.astonsci.comRevenue
$6.7 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Aston Science
Aston Science is a clinical-stage biopharmaceutical company based on a pipeline portfolio of innovative medicines with a focus on therapeutic cancer vaccines.Explore more
Aston Science Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Aston Science your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Aston Science had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Aston Science
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Aston Science, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Aston Science launches new products
Check out if Aston Science is spiking on competitors!
Funding: Get notified immidiatlly once Aston Science has new funding data
Website visits: Recent activity has been detected on your website
Check if Aston Science has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Aston Science recently announced quarterly report
Recommended Actions
Reach out to Masked Content who joined Aston Science as Masked Content
Find 2 more new buyers
Company Profile Activity
Activity Insights
Aston Science is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Aston Science is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Aston Science.
Aston Science financials insights
Gather financial insights about Aston Science, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2022
Series C
$22.7M
Aston Science Tech Stack
A closer look at the technologies used by Aston Science
See more technologies
Aston Science News & Media
Aston Sci. Receives IND Approval from U.S. FDA for Phase 2 Clinical Trial of the Therapeutic Cancer Vaccine AST-301 in Patients with HER2 1+/2+ Breast Cancer
- CornerStone-001(NCT05163223), the multiregional clinical trial for breast cancer treatment, received U.S. FDA approval for Phase 2 trial following the approvals in Australia and the Taiwan region. - As the same patient group and design of a pivotal study are adopted, a...Aston Sci. Raises USD 22.7 Million Series C Funding
SEOUL, South Korea--(BUSINESS WIRE)-- #AST301--Aston Sci., a clinical-stage biopharmaceutical company, raised USD 22.7 million Series C funding being recognized its clinical development capacity.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Aston Science
Sign Up For FreeTo access detailed company insights
Aston Science is a clinical-stage biopharmaceutical company based on a pipeline portfolio of innovative medicines with a focus on therapeutic cancer vaccines.... Read More
